Liver Metastasis Colon Cancer Clinical Trials

14 recruiting

Liver Metastasis Colon Cancer Trials at a Glance

14 actively recruiting trials for liver metastasis colon cancer are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Aarhus, Aarhus, and Aarhus N. Lead sponsors running liver metastasis colon cancer studies include Azienda Ospedaliero-Universitaria di Modena, Claus Lindbjerg Andersen, and Aarhus University Hospital.

Browse liver metastasis colon cancer trials by phase

Treatments under study

About Liver Metastasis Colon Cancer Clinical Trials

Looking for clinical trials for Liver Metastasis Colon Cancer? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Liver Metastasis Colon Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Liver Metastasis Colon Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Liver CancerMelanomaMerkel Cell Carcinoma+9 more
Istituto Oncologico Veneto IRCCS24 enrolled1 locationNCT06753136
Recruiting

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Colon CancerLiver Metastasis Colon CancerAdenocarcinoma of the Rectum+2 more
Memorial Sloan Kettering Cancer Center80 enrolled1 locationNCT04668872
Recruiting

Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases

Liver Metastasis Colon Cancer
Aarhus University Hospital30 enrolled1 locationNCT04491929
Recruiting
Not Applicable

LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis

Liver Metastasis Colon CancerColon Adenocarcinoma
Azienda Ospedaliero-Universitaria di Modena25 enrolled1 locationNCT05186116
Recruiting

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors

Liver CancerHepatocellular CarcinomaLiver Metastases+1 more
Leiden University Medical Center1,500 enrolled1 locationNCT06179602
Recruiting

On-treatment Biomarkers in Metastatic Colorectal Cancer for Life

Metastatic Colorectal CancerChemotherapy EffectPeritoneal Metastases+2 more
Region Skane100 enrolled2 locationsNCT05755672
Recruiting
Not Applicable

Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer

Liver Metastasis Colon Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's200 enrolled2 locationsNCT05314400
Recruiting
Not Applicable

TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery

Liver CancerLiver MetastasesLiver Neoplasms+1 more
Medical University of Warsaw154 enrolled1 locationNCT06050200
Recruiting

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

Liver Metastasis Colon CancerColorectal Cancer Stage III
Claus Lindbjerg Andersen590 enrolled15 locationsNCT06111105
Recruiting
Not Applicable

Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation

Liver Metastasis Colon Cancer
University of Aarhus200 enrolled1 locationNCT04798898
Recruiting
Not Applicable

Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

Liver Metastasis Colon CancerLiver DysfunctionLiver Regeneration
McGill University Health Centre/Research Institute of the McGill University Health Centre70 enrolled1 locationNCT06126419
Recruiting

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Liver CancerRenal Cell CarcinomaKidney Cancer+1 more
Francesco De Cobelli500 enrolled1 locationNCT03981497
Recruiting
Not Applicable

LT for Unresectable Colorectal Liver Metastasis

Liver Metastasis Colon Cancer
Seoul National University Hospital20 enrolled1 locationNCT04874259
Recruiting
Not Applicable

Liver Transplantation for Non-Resectable Colorectal Liver Metastasis

Liver Metastasis Colon Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna20 enrolled1 locationNCT05185245